News & Perspective

Nov 04, 2004

Nov 04, 2004

HHS to spend $877 million on new anthrax vaccine

Editor's note: A correction was made in this story Nov 9 to note that the existing licensed anthrax vaccine contains the natural rather than recombinant form of anthrax protective antigen.

(CIDRAP News) – Federal health officials today announced the award of an $877 million contract for 75 million doses of a new anthrax vaccine to protect the public and improve on the existing vaccine used by the military.

Mar 12, 2004

Mar 12, 2004

FDA offers guidance on testing drugs for smallpox-shot side effects

(CIDRAP News) – The Food and Drug Administration (FDA) this week published guidelines for the development of drugs to treat the side effects of smallpox vaccination, an area in which the federal government is investing substantial research funds.